Figure 2.

Kaplan-Meier estimates for freedom from tumor progression (FFTP) and overall survival (OS) according to c-Met expression. c-Met positivity of HRS cells correlated with very favorable FFTP in both the German (A) and the Dutch (B) cohorts. In the combined cohort, c-Met expression again correlated with favorable FFTP (C) and OS (D) and was independent of disease stage (E and F). Especially among patients with advanced stage disease (F), absence of c-Met correlated with a low 5-year FFTP rate (57%) compared to the rate in patients who were c-Met-positive (91%).